Daya-Grosjean L, Robert C, Drougard C, Suarez H, Sarasin A
Laboratory of Molecular Genetics, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France.
Cancer Res. 1993 Apr 1;53(7):1625-9.
Xeroderma pigmentosum (XP) patients are clinically characterized by a very high incidence of skin cancers on exposed skin, at an early age. XP cells in vitro are strongly deficient in excision-repair and highly mutagenized by UV light. We were, therefore, interested in measuring mutation frequency and in determining mutation spectra in patients' tumors exposed to UV lesions. We chose to look at oncogene activation in skin tumors with the idea that more mutations, particularly of the ras gene family, would be found in XP tumors where lesions remain unrepaired compared to normal individuals. Our results clearly show that more than a 2-fold significantly higher mutation frequency (50%) of the ras genes was found in XP in contrast to control tumors (22%). The majority of the mutations were found at codon 12 of all three ras genes with a preponderance for N-ras in XP samples. The mutation spectra indicate that all mutations found were located opposite pyrimidine-pyrimidine sequences which represent a hot spot for UV-induced DNA lesions. Most of the mutations were of the type expected from studies performed in vitro with model systems. This high mutation frequency in XP was accompanied by a very high level of Ha-ras and c-myc gene amplification and rearrangement. All these data are consistent with a fundamental role of unrepaired UV-induced DNA lesions as an initiating event in human skin tumors on exposed parts of the body.
着色性干皮病(XP)患者的临床特征是在早年时,暴露皮肤上皮肤癌的发病率非常高。XP细胞在体外严重缺乏切除修复能力,并且对紫外线高度敏感而发生诱变。因此,我们有兴趣测量患者暴露于紫外线损伤的肿瘤中的突变频率,并确定突变谱。我们选择研究皮肤肿瘤中的癌基因激活情况,认为与正常个体相比,在XP肿瘤中,由于损伤未得到修复,会发现更多的突变,特别是ras基因家族的突变。我们的结果清楚地表明,与对照肿瘤(22%)相比,XP肿瘤中ras基因的突变频率显著高出两倍多(50%)。在所有三个ras基因的第12密码子处发现了大多数突变,在XP样本中N-ras占优势。突变谱表明,所有发现的突变都位于嘧啶-嘧啶序列的对面,这是紫外线诱导的DNA损伤的热点。大多数突变是在体外模型系统研究中预期的类型。XP中的这种高突变频率伴随着Ha-ras和c-myc基因的高水平扩增和重排。所有这些数据都与未修复的紫外线诱导的DNA损伤作为人体暴露部位皮肤肿瘤起始事件的基本作用一致。